DOI QR코드

DOI QR Code

Association between periodontal bacteria and degenerative aortic stenosis: a pilot study

  • Kataoka, Akihisa (Division of Cardiology, Department of Medicine, Teikyo University) ;
  • Katagiri, Sayaka (Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University) ;
  • Kawashima, Hideyuki (Division of Cardiology, Department of Medicine, Teikyo University) ;
  • Nagura, Fukuko (Division of Cardiology, Department of Medicine, Teikyo University) ;
  • Nara, Yugo (Division of Cardiology, Department of Medicine, Teikyo University) ;
  • Hioki, Hirofumi (Division of Cardiology, Department of Medicine, Teikyo University) ;
  • Nakashima, Makoto (Division of Cardiology, Department of Medicine, Teikyo University) ;
  • Sasaki, Naoki (Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University) ;
  • Hatasa, Masahiro (Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University) ;
  • Maekawa, Shogo (Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University) ;
  • Ohsugi, Yujin (Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University) ;
  • Shiba, Takahiko (Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University) ;
  • Watanabe, Yusuke (Division of Cardiology, Department of Medicine, Teikyo University) ;
  • Shimokawa, Tomoki (Department of Cardiovascular Surgery, Teikyo University) ;
  • Iwata, Takanori (Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University) ;
  • Kozuma, Ken (Division of Cardiology, Department of Medicine, Teikyo University)
  • Received : 2020.09.06
  • Accepted : 2021.03.05
  • Published : 2021.08.30

Abstract

Purpose: Although several reports have described the relationship between periodontal disease and cardiovascular disease, information about the association between periodontal disease and the progression of degenerative aortic stenosis (AS) is lacking. Therefore, we performed a retrospective, single-center, pilot study to provide insight into this potential association. Methods: Data from 45 consecutive patients (19 men; median age, 83 years) with mild or moderate degenerative aortic stenosis were analyzed for a mean observation period of 3.3±1.9 years. The total amount of Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis and titers of serum immunoglobulin G (IgG) against periodontal bacteria and high-sensitivity C-reactive protein (hs-CRP) were evaluated. Aortic valve area (AVA), maximal velocity (Vmax), mean pressure gradient (mean PG), and the Doppler velocity index (DVI) were evaluated. The change in each parameter per year ([ParameterLATEST-ParameterBASELINE]/Follow-up Years) was calculated from the retrospective follow-up echocardiographic data (baseline vs. the most recently collected data [latest]). Results: No correlation was found between the concentration of periodontopathic bacteria in the saliva and AS status/progression. The anti-P. gingivalis antibody titer in the serum showed a significant positive correlation with AVA and DVI. Additionally, there was a negative correlation between the anti-P. gingivalis IgG antibody titer and mean PG. The hs-CRP concentration showed positive correlations with Vmax and mean PG. Meanwhile, a negative correlation was observed between the anti-P. gingivalis IgG antibody titer and ΔAVA/year and Δmean PG/year. The hs-CRP concentration showed positive correlations with Vmax and mean PG, and it was significantly higher in patients with rapid aortic stenosis progression (ΔAVA/year <-0.1) than in their counterparts. Conclusions: Our results suggest that periodontopathic bacteria such as A. actinomycetemcomitans and P. gingivalis are not directly related to the status/progression of degenerative AS. However, inflammation and a lower immune response may be associated with disease progression.

Keywords

Acknowledgement

We thank Ms. Aki Takahashi, who is a technician at Teikyo University, for providing technical support.

References

  1. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-20. https://doi.org/10.1016/S0140-6736(05)67728-8
  2. Genco RJ, Van Dyke TE. Prevention: reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol 2010;7:479-80. https://doi.org/10.1038/nrcardio.2010.120
  3. Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007;154:830-7. https://doi.org/10.1016/j.ahj.2007.06.037
  4. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ Jr. Communication among oral bacteria. Microbiol Mol Biol Rev 2002;66:486-505. https://doi.org/10.1128/MMBR.66.3.486-505.2002
  5. Katagiri S, Nitta H, Nagasawa T, Uchimura I, Izumiyama H, Inagaki K, et al. Multi-center intervention study on glycohemoglobin (HbA1c) and serum, high-sensitivity CRP (hs-CRP) after local anti-infectious periodontal treatment in type 2 diabetic patients with periodontal disease. Diabetes Res Clin Pract 2009;83:308-15. https://doi.org/10.1016/j.diabres.2008.10.016
  6. Page RC. The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Ann Periodontol 1998;3:108-20. https://doi.org/10.1902/annals.1998.3.1.108
  7. Koren O, Spor A, Felin J, Fak F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A 2011;108 Suppl 1:4592-8.
  8. Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 2008;23:2079-86. https://doi.org/10.1007/s11606-008-0787-6
  9. Salvi GE, Carollo-Bittel B, Lang NP. Effects of diabetes mellitus on periodontal and peri-implant conditions: update on associations and risks. J Clin Periodontol 2008;35:398-409.
  10. Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol 2012;12:16. https://doi.org/10.1186/1471-230X-12-16
  11. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-26. https://doi.org/10.1161/CIRCULATIONAHA.104.486738
  12. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-5. https://doi.org/10.1161/CIRCULATIONAHA.104.495903
  13. Chen YW, Umeda M, Nagasawa T, Takeuchi Y, Huang Y, Inoue Y, et al. Periodontitis may increase the risk of peripheral arterial disease. Eur J Vasc Endovasc Surg 2008;35:153-8. https://doi.org/10.1016/j.ejvs.2007.08.016
  14. Sakurai K, Wang D, Suzuki J, Umeda M, Nagasawa T, Izumi Y, et al. High incidence of Actinobacillus actinomycetemcomitans infection in acute coronary syndrome. Int Heart J 2007;48:663-75. https://doi.org/10.1536/ihj.48.663
  15. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:e57-185.
  16. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1-39.e14.
  17. Udagawa S, Katagiri S, Maekawa S, Takeuchi Y, Komazaki R, Ohtsu A, et al. Effect of Porphyromonas gingivalis infection in the placenta and umbilical cord in pregnant mice with low birth weight. Acta Odontol Scand 2018;76:433-41. https://doi.org/10.1080/00016357.2018.1426876
  18. Komazaki R, Katagiri S, Takahashi H, Maekawa S, Shiba T, Takeuchi Y, et al. Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism. Sci Rep 2017;7:13950. https://doi.org/10.1038/s41598-017-14260-9
  19. Ohtsu A, Takeuchi Y, Katagiri S, Suda W, Maekawa S, Shiba T, et al. Influence of Porphyromonas gingivalis in gut microbiota of streptozotocin-induced diabetic mice. Oral Dis 2019;25:868-80. https://doi.org/10.1111/odi.13044
  20. Wang D, Kawashima Y, Nagasawa T, Takeuchi Y, Kojima T, Umeda M, et al. Elevated serum IgG titer and avidity to Actinobacillus actinomycetemcomitans serotype c in Japanese periodontitis patients. Oral Microbiol Immunol 2005;20:172-9. https://doi.org/10.1111/j.1399-302X.2005.00208.x
  21. Rocas IN, Siqueira JF Jr, Santos KR, Coelho AM, de Janeiro R. "Red complex" (Bacteroides forsythus, Porphyromonas gingivalis, and Treponema denticola) in endodontic infections: a molecular approach. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:468-71. https://doi.org/10.1067/moe.2001.114379
  22. Baehni P, Tsai CC, McArthur WP, Hammond BF, Taichman NS. Interaction of inflammatory cells and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived gram-negative microorganism. Infect Immun 1979;24:233-43. https://doi.org/10.1128/iai.24.1.233-243.1979
  23. Mandell RL, Socransky SS. A selective medium for Actinobacillus actinomycetemcomitans and the incidence of the organism in juvenile periodontitis. J Periodontol 1981;52:593-8. https://doi.org/10.1902/jop.1981.52.10.593
  24. Fine DH, Markowitz K, Furgang D, Fairlie K, Ferrandiz J, Nasri C, et al. Aggregatibacter actinomycetemcomitans and its relationship to initiation of localized aggressive periodontitis: longitudinal cohort study of initially healthy adolescents. J Clin Microbiol 2007;45:3859-69. https://doi.org/10.1128/JCM.00653-07
  25. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207-14. https://doi.org/10.1038/nature11234
  26. Damgaard C, Danielsen AK, Enevold C, Massarenti L, Nielsen CH, Holmstrup P, et al. Porphyromonas gingivalis in saliva associates with chronic and aggressive periodontitis. J Oral Microbiol 2019;11:1653123. https://doi.org/10.1080/20002297.2019.1653123
  27. Cortelli SC, Feres M, Rodrigues AA, Aquino DR, Shibli JA, Cortelli JR. Detection of Actinobacillus actinomycetemcomitans in unstimulated saliva of patients with chronic periodontitis. J Periodontol 2005;76:204-9. https://doi.org/10.1902/jop.2005.76.2.204
  28. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation 2012;125:2520-44. https://doi.org/10.1161/CIR.0b013e31825719f3
  29. Aoyama N, Kobayashi N, Hanatani T, Ashigaki N, Yoshida A, Shiheido Y, et al. Periodontal condition in Japanese coronary heart disease patients: a comparison between coronary and non-coronary heart diseases. J Periodontal Res 2019;54:259-65. https://doi.org/10.1111/jre.12626
  30. Aoyama N, Kure K, Minabe M, Izumi Y. Increased heart failure prevalence in patients with a high antibody level against periodontal pathogen. Int Heart J 2019;60:1142-6. https://doi.org/10.1536/ihj.19-010
  31. Horibe M, Watanabe H, Ishikawa I. Effect of periodontal treatments on serum IgG antibody titers against periodontopathic bacteria. J Clin Periodontol 1995;22:510-5. https://doi.org/10.1111/j.1600-051X.1995.tb00798.x
  32. Frasca D, Blomberg BB. Aging affects human B cell responses. J Clin Immunol 2011;31:430-5. https://doi.org/10.1007/s10875-010-9501-7
  33. Emerging Risk Factors CollaborationKaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367:1310-20. https://doi.org/10.1056/NEJMoa1107477
  34. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. https://doi.org/10.1161/01.CIR.0000053730.47739.3C
  35. Blyme A, Asferg C, Nielsen OW, Sehestedt T, Kesaniemi YA, Gohlke-Barwolf C, et al. High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy. Open Heart 2015;2:e000152. https://doi.org/10.1136/openhrt-2014-000152
  36. Blyme A, Asferg C, Nielsen OW, Boman K, Gohlke-Barwolf C, Wachtell K, et al. Increased hsCRP is associated with higher risk of aortic valve replacement in patients with aortic stenosis. Scand Cardiovasc J 2016;50:138-45. https://doi.org/10.3109/14017431.2016.1151928
  37. Pawade TA, Newby DE, Dweck MR. Calcification in aortic stenosis: the skeleton key. J Am Coll Cardiol 2015;66:561-77. https://doi.org/10.1016/j.jacc.2015.05.066
  38. New SE, Aikawa E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ Res 2011;108:1381-91. https://doi.org/10.1161/CIRCRESAHA.110.234146
  39. Raffaelli L, Santangelo R, Falchetti P, Galluccio F, Luciani N, Anselmi A, et al. Examination of periodontal pathogens in stenotic valve specimens and in whole blood samples in patients affected by aortic valve stenosis and chronic periodontitis. Int J Immunopathol Pharmacol 2010;23:561-6. https://doi.org/10.1177/039463201002300218
  40. Kudo C, Naruishi K, Maeda H, Abiko Y, Hino T, Iwata M, et al. Assessment of the plasma/serum IgG test to screen for periodontitis. J Dent Res 2012;91:1190-5. https://doi.org/10.1177/0022034512461796